Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT05702229 · RECRUITING
Trial details
- NCT number
- NCT05702229
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-16
- Primary completion
- 2027-11-30
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.